VivoSim Labs (VIVS) Operating Expenses (2010 - 2026)
VivoSim Labs (VIVS) posted Operating Expenses of $2.8 million for Q2 2026, down 13.94% on a QoQ basis from $3.2 million in Q1 2026, and down 5.93% year-over-year from $3.0 million in Q2 2025.
Analysis
VivoSim Labs (VIVS) Operating Expenses (2010 - 2026) Analysis & Trends
VivoSim Labs has reported Operating Expenses for 17 years, with the latest figure at $2.8 million in Q2 2026.
- On a quarterly basis, Operating Expenses fell 5.93% year-over-year to $2.8 million in Q2 2026; TTM through Jun 2026 was $11.4 million, a 6.87% decrease from a year earlier, with the FY2026 full-year figure at $11.6 million, down 8.95% from the prior year.
- Operating Expenses was $2.8 million for Q2 2026 at VivoSim Labs, down from $3.2 million in the prior quarter.
- The five-year high for Operating Expenses was $7.9 million in Q1 2023, with the low at $2.6 million in Q3 2024.
- Average Operating Expenses over 5 years is $3.5 million, with a median of $3.3 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 132.67% in 2023, then plunged 60.65% in 2024.
- Over 5 years, Operating Expenses stood at $3.5 million in 2022, then advanced by 5.59% to $3.7 million in 2023, then decreased by 5.24% to $3.5 million in 2024, then retreated by 20.5% to $2.8 million in 2025, then advanced by 0.04% to $2.8 million in 2026.
- The last three Operating Expenses figures came in at $2.8 million (Q2 2026), $3.2 million (Q1 2026), and $2.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 637.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 560.51 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 1.93 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 228.90 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 663.40 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 78.70 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 15.64 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 6.01 Bn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 2.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.78 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | 2.66 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 3.21 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Sep 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 4.12 Mn |
| Jun 30, 2023 | 4.27 Mn |
| Mar 31, 2023 | 7.94 Mn |
| Dec 31, 2022 | 3.49 Mn |
| Sep 30, 2022 | 3.43 Mn |
| Jun 30, 2022 | 3.24 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 3.50 Mn |
| Sep 30, 2021 | 3.51 Mn |